3,417
Participants
Start Date
April 1, 2004
Primary Completion Date
December 31, 2015
Study Completion Date
May 31, 2017
vincristine, carboplatin
"vincristine: 1,5 mg/m² i.v., week 1,2,3,4,5,6,7,8,9,10,13,17,21~carboplatin: 550 mg/m² i.v., week 1,4,7,10,13,17,21"
vincristine, carboplatin, etoposide
"vincristine: 1,5 mg/m² i.v., week 1,2,3,4,5,6,7,8,9,10,13,17,21~carboplatin: 550 mg/m² i.v., week 1,4,7,10,13,17,21~etoposide: 100 mg/m² i.v., week 1,4,7,10"
radiation therapy
"intracranial tumor site: 30 fractions, dose per fraction: 1.8 Gy, total dose: 54 Gy, duration 6 weeks~spinal tumor site: 28 fractions, dose per fraction: 1.8 Gy, total dose: 50.4 Gy duration 5 1/2 weeks"
Allg. Krankenhaus der Stadt Wien Universitaets-Kinderklinik, Vienna
Hospital San Joao, Porto
Aalborg Hospital, Aalborg
Children's Hospital Zagreb, Zagreb
Azienda Ospedaliera di Padova, Padua
Universitair Ziekenhuis Gent, Ghent
Institut Gustave Roussy, Villejuif
Klinikum Augsburg, Augsburg
University of Tromso, Tromsø
Children's Memorial Health Institute, Warsaw
University Children's Hospital, Zurich
Leeds Cancer Centre at St. James's University Hospital, Leeds
Queen's Medical Centre, Nottingham
Societe Internationale d'Oncologie Pediatrique
OTHER